In conclusion, the SCAMP1/miR‐499a‐5p/LMX1A/NLRC5 axis serves as a critical regulator of tumourigenesis and progression of glioma, providing a novel therapeutic strategy for glioma treatment. Here, NLRC5 is linked to glioma.